The Lancet Neurology in conversation with
Episodes
Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer's disease
18 Mar 2026
Contributed by Lukas
In this episode, Laura Hart and Elena Becker-Barroso speak with Niklas Mattsson-Carlgren (Lund University) about the use of blood biomarkers in the di...
Cristina Tassorelli on migraine prevention
18 Feb 2026
Contributed by Lukas
In this episode, Senior Editor Morgane Boillot speaks with Professor Cristina Tassorelli (University of Pavia, Italy) about recent advances in migrain...
Inga Zerr and Simon Mead on advances in prion diseases
21 Jan 2026
Contributed by Lukas
Our Editor-in-Chief, Elena Becker-Barroso, speaks with Inga Zerr (DZNE, Göttingen, Germany) and Simon Mead (UCL London, UK) about the latest advances...
Julia Greenland on azathioprine for early Parkinson's disease
19 Dec 2025
Contributed by Lukas
Host Morgane Boillot chats with Dr Julia Greenland about a clinical trial of azathioprine in early Parkinson's disease. Click here to read the f...
Ian McKeith on dementia with dementia with Lewy bodies
12 Nov 2025
Contributed by Lukas
In this episode, host Antonia Eisenkoeck, speaks with Ian McKeith, Emeritus Professor of Old Age Psychiatry at Newcastle University, UK. They delve in...
Ask Nordestgaard on long-term stroke risk in women
15 Oct 2025
Contributed by Lukas
In this episode, host Laura Hart chats with Ask Nordestgaard (Brigham and Women's Hospital, Boston, USA) about the long-term risk of stroke in he...
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis
17 Sep 2025
Contributed by Lukas
Morgane Boillot chats with Professor Shiv Saidha (Johns Hopkins University, USA) about recent developments in diagnosing multiple sclerosis, and speci...
Michael Rafii on Down syndrome-related Alzheimer’s disease
13 Aug 2025
Contributed by Lukas
People with Down syndrome face a high risk of developing Alzheimer’s disease, which is the leading cause of death in this population over the age of...
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
16 Jul 2025
Contributed by Lukas
In this episode, host Laura Hart chats with Professor Amit Bar-Or (University of Pennsylvania) about the potential of the BTK inhibitor fenebrutinib i...
Marte-Helene Bjørk on reproductive risks in people with epilepsy
17 Jun 2025
Contributed by Lukas
Sarah Passey is joined by Dr Marte-Helene Bjørk (Haukeland University Hospital, Norway) to discuss the latest evidence and practical guidance on mana...
Geoff Manley on a new classification system for traumatic brain injury
20 May 2025
Contributed by Lukas
Assistant Editor Sam Griffiths is joined by Professor Geoff Manley (UCSF, CA, USA) to discuss his new NIH-NINDS classification of acute TBI, the limit...
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
16 Apr 2025
Contributed by Lukas
Increasing numbers of people are surviving stroke but with motor impairments that can contribute substantially to long-term disability. Transcranial ...
Marialuisa Gandolfi on the management of chronic pain in Parkinson's disease
19 Mar 2025
Contributed by Lukas
In this podcast, linked to the April 2025 issue of The Lancet Neurology, Laura Hart (Deputy Editor) chats to Marialuisa Gandolfi (University of Verona...
Michael Tymianski on neuroprotection in stroke
19 Feb 2025
Contributed by Lukas
Sarah Passey (The Lancet Neurology) is joined by Michael Tymianski (University Health Network, Toronto, Canada) to discuss an Article in the March iss...
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
22 Jan 2025
Contributed by Lukas
In this podcast, linked to the February 2025 issue of The Lancet Neurology, Elena Becker-Barroso (Editor-in-Chief) chats to Elizabeth Finger (Western ...
The Lancet Neurology Editors on advances in neurology in 2024
18 Dec 2024
Contributed by Lukas
The Lancet Neurology Editors take a look back at advances in neurology in 2024, as highlighted by experts in a series of Round-ups published in the Ja...
Florian Krismer and Elizabeth Coon on multiple system atrophy
20 Nov 2024
Contributed by Lukas
Florian Krismer (Innsbruck Medical University) and Elizabeth Coon (Mayo Clinic) join Sarah Passey (The Lancet Neurology) to discuss their Review paper...
Suvankar Pal on the motor neuron disease trial MND-SMART
16 Oct 2024
Contributed by Lukas
Professor Suvankar Pal (University of Edinburgh) joins Sarah Passey (Senior Editor at The Lancet Neurology) to discuss the first findings from the MND...
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
18 Sep 2024
Contributed by Lukas
Prof Jorge Correale and Dr Lilyana Amezcua talk to The Lancet Neurology about their Personal View papers, published in the October 2024 issue, on the ...
Alex Iranzo on sleep and Parkinson's disease
14 Aug 2024
Contributed by Lukas
Dr Alex Iranzo joins The Lancet Neurology to discuss his recent Review on the association between sleep disorders and Parkinson's disease. The Re...
Adrian Owen on detecting awareness after acute brain injury
17 Jul 2024
Contributed by Lukas
Dr Adrian Owen joins Sarah Passey to chat about a his Personal View, published in the August 2024 issue of The Lancet Neurology, about detecting aware...
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
12 Jun 2024
Contributed by Lukas
Dr Glenn Nielsen joins Lauren Southwell to discuss the Physio4FMD trial of specialist physiotherapy for people with functional motor disorder in Engla...
Sanjay Sisodiya on climate change and brain health
15 May 2024
Contributed by Lukas
Sanjay Sisodiya joins The Lancet Neurology to discuss the potential effects of climate change on brain health. The Personal View is published in the J...
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
15 Apr 2024
Contributed by Lukas
Jacqueline French and Jacob Pellinen join Senior Editor Sarah Passey to discuss recent progress made in the diagnosis of epilepsy and challenges that ...
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
14 Mar 2024
Contributed by Lukas
Jaimie Steinmetz and Theo Vos from the Institute for Health Metrics and Evaluation, and Katrin Seeher and Tarun Dua from WHO, join Heather Brown and L...
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
14 Feb 2024
Contributed by Lukas
Giovanni Frisoni joins The Lancet Neurology to discuss new European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive ...
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
22 Jan 2024
Contributed by Lukas
Marianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published...
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
13 Dec 2023
Contributed by Lukas
Cecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease pr...
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
15 Nov 2023
Contributed by Lukas
Rustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet ...
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations
20 Oct 2023
Contributed by Lukas
Njideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed indivi...
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
20 Sep 2023
Contributed by Lukas
Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive reha...
William Jagust on amyloid β and cognition
16 Aug 2023
Contributed by Lukas
William Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and co...
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
19 Jul 2023
Contributed by Lukas
Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patie...
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
21 Jun 2023
Contributed by Lukas
Benzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenn...
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
18 May 2023
Contributed by Lukas
Andrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying e...
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
13 Apr 2023
Contributed by Lukas
Karen Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this grou...
Kerstin Hellwig on family planning considerations in MS
15 Mar 2023
Contributed by Lukas
Kerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in ...
Geraldine Dawson on advances in the prediction of autism during infancy
16 Feb 2023
Contributed by Lukas
Geraldine Dawson (Duke University School of Medicine, NC, USA ) discusses the latest advances and ongoing challenges in prediction of autism during in...
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
19 Jan 2023
Contributed by Lukas
Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which in...
Beau Ances on amyloid biomarkers in Alzheimer’s
12 Dec 2022
Contributed by Lukas
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s ...
Axel Petzold on the diagnosis and classification of optic neuritis
16 Nov 2022
Contributed by Lukas
Axel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amste...
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
18 Oct 2022
Contributed by Lukas
Maeike Zijlmans (University Medical Center Utrecht, Utrecht, Netherlands) discusses recent research on tailoring of epilepsy surgery with biomarkers o...
Jerome Siegel on sleep habits
14 Sep 2022
Contributed by Lukas
Jerome Siegel (University of California, Los Angeles, CA, USA) discusses sleep research in hunter-gatherer populations and what we can learn from the ...
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
10 Aug 2022
Contributed by Lukas
Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is ...
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
13 Jul 2022
Contributed by Lukas
Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria ...
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies
15 Jun 2022
Contributed by Lukas
Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on H...
Mark Hallett on functional neurological disorder
13 May 2022
Contributed by Lukas
Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lan...
Eva Feldman on advances in understanding ALS
13 Apr 2022
Contributed by Lukas
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic develop...
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's
06 Apr 2022
Contributed by Lukas
Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, publishe...
John Collinge on a treatment for CJD
16 Mar 2022
Contributed by Lukas
John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-pro...
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
22 Feb 2022
Contributed by Lukas
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with ...
Giuseppe Citerio on frailty and TBI
19 Jan 2022
Contributed by Lukas
Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frail...
Alberto Costa on memantine in adolescents and young adults with Down syndrome
20 Dec 2021
Contributed by Lukas
Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with D...
Olivier Rascol on amantadine for patients with movement disorders
17 Nov 2021
Contributed by Lukas
Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focu...
Antonio Uccelli on stems cells for MS
20 Oct 2021
Contributed by Lukas
Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology, on the therapeutic use of mesen...
Priya Palta on blood pressure control and cognitive decline
15 Sep 2021
Contributed by Lukas
Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, publ...
Adam Boxer on tau biomarkers
18 Aug 2021
Contributed by Lukas
Adam Boxer (University of California, San Francisco) discusses his research, published in August issue of The Lancet Neurology, on diagnostic performa...
Irene Cortese on the difficulties of designing clinical trials
21 Jul 2021
Contributed by Lukas
Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifo...
Doug Turnbull on mitochondrial diseases in adults
16 Jun 2021
Contributed by Lukas
Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology, and ...
Geert Jan Biessels on predicting post-stroke cognitive impairment
19 May 2021
Contributed by Lukas
Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in our June issue, on using strategic infarct locations to pr...
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
21 Apr 2021
Contributed by Lukas
Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS.Read the full article:https://www.thelancet.com/...
Anne MacGregor on menstrual migraine
17 Mar 2021
Contributed by Lukas
Anne MacGregor discusses her recent Review of menstrual migraine, and explains why the problem needs greater recognition.Read the full article:https:/...
Peter Rothwell on asymptomatic carotid stenosis and stroke
17 Feb 2021
Contributed by Lukas
Peter Rothwell (Oxford University) discusses his research, found in our new issue, on asymptomatic carotid stenosis and stroke.Read the full article:h...
Spinal cord injury and degenerative cervical myelopathy
20 Jan 2021
Contributed by Lukas
Professor Michael Fehlings discusses the implications of his two papers in the Jan 2021 issue of The Lancet Neurology.Read the full article:https://ww...
Genetic risk factors for sCJD
22 Dec 2020
Contributed by Lukas
Emma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfel...
Prednisone in short-term prevention of cluster headache
24 Nov 2020
Contributed by Lukas
Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.Continue this conversation on soci...
PET imaging of inflammation in neurological and psychiatric disorders
21 Oct 2020
Contributed by Lukas
Robert Innis discusses his work on measuring neuroinflammation using PET imaging.Continue this conversation on social!Follow us today at...https://the...